Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
6043 | 1539 | 34.0 | 63% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
429 | 3 | SPHINGOSINE 1 PHOSPHATE//CERAMIDE//SPHINGOLIPIDS | 27734 |
1114 | 2 | PHOSPHOLIPASE A2//PLASMALOGEN//LIPIDOMICS | 9711 |
6043 | 1 | ALKYLPHOSPHOCHOLINES//HEXADECYLPHOSPHOCHOLINE//EDELFOSINE | 1539 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ALKYLPHOSPHOCHOLINES | authKW | 972100 | 4% | 78% | 63 |
2 | HEXADECYLPHOSPHOCHOLINE | authKW | 905050 | 4% | 72% | 63 |
3 | EDELFOSINE | authKW | 830448 | 4% | 70% | 60 |
4 | ALKYL LYSOPHOSPHOLIPIDS | authKW | 676622 | 2% | 95% | 36 |
5 | PERIFOSINE | authKW | 609566 | 3% | 59% | 52 |
6 | ALKYLPHOSPHOLIPIDS | authKW | 533341 | 2% | 79% | 34 |
7 | ET 18 OCH3 | authKW | 463458 | 2% | 81% | 29 |
8 | ERUFOSINE | authKW | 301763 | 1% | 89% | 17 |
9 | ERUCYLPHOSPHOCHOLINE | authKW | 243028 | 1% | 88% | 14 |
10 | ETHER LIPIDS | authKW | 230591 | 3% | 25% | 46 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 3899 | 27% | 0% | 418 |
2 | Chemistry, Organic | 1972 | 17% | 0% | 267 |
3 | Biochemistry & Molecular Biology | 1641 | 30% | 0% | 458 |
4 | Biophysics | 1372 | 12% | 0% | 180 |
5 | Chemistry, Medicinal | 889 | 8% | 0% | 120 |
6 | Pharmacology & Pharmacy | 594 | 14% | 0% | 212 |
7 | Nutrition & Dietetics | 367 | 5% | 0% | 72 |
8 | Chemistry, Multidisciplinary | 111 | 9% | 0% | 133 |
9 | Hematology | 81 | 3% | 0% | 47 |
10 | Cell Biology | 56 | 5% | 0% | 81 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CHEM POLYMERS TECHNOL | 99197 | 0% | 100% | 5 |
2 | BIOL MOL CELULAR CANC | 98146 | 3% | 11% | 45 |
3 | INVEST CANC | 62372 | 3% | 7% | 44 |
4 | TOXICOL CHEMOTHER Y UNIT | 48374 | 1% | 24% | 10 |
5 | UNIT TOXICOL CHEMOTHER Y | 41316 | 1% | 21% | 10 |
6 | SCI ST JEROME D12 | 26451 | 0% | 67% | 2 |
7 | AG TOXICOL CHEMOTHER IE 0426 | 19839 | 0% | 100% | 1 |
8 | BIOL CYTOL HISTOL EMBRYOL | 19839 | 0% | 100% | 1 |
9 | BIOPHYS INSERM U201 | 19839 | 0% | 100% | 1 |
10 | BOSTON VET ADM VA HEALTHCARE SYST | 19839 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CHEMISTRY AND PHYSICS OF LIPIDS | 57748 | 6% | 3% | 97 |
2 | PROGRESS IN EXPERIMENTAL TUMOR RESEARCH | 21128 | 1% | 7% | 15 |
3 | LIPIDS | 14164 | 4% | 1% | 65 |
4 | BIOORGANICHESKAYA KHIMIYA | 13388 | 3% | 1% | 47 |
5 | JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING | 3496 | 0% | 3% | 7 |
6 | ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY | 2661 | 1% | 1% | 12 |
7 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 2550 | 2% | 0% | 31 |
8 | DRUGS OF TODAY | 1767 | 1% | 1% | 12 |
9 | ONKOLOGIE | 1477 | 1% | 1% | 14 |
10 | RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY | 1370 | 1% | 1% | 10 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ALKYLPHOSPHOCHOLINES | 972100 | 4% | 78% | 63 | Search ALKYLPHOSPHOCHOLINES | Search ALKYLPHOSPHOCHOLINES |
2 | HEXADECYLPHOSPHOCHOLINE | 905050 | 4% | 72% | 63 | Search HEXADECYLPHOSPHOCHOLINE | Search HEXADECYLPHOSPHOCHOLINE |
3 | EDELFOSINE | 830448 | 4% | 70% | 60 | Search EDELFOSINE | Search EDELFOSINE |
4 | ALKYL LYSOPHOSPHOLIPIDS | 676622 | 2% | 95% | 36 | Search ALKYL+LYSOPHOSPHOLIPIDS | Search ALKYL+LYSOPHOSPHOLIPIDS |
5 | PERIFOSINE | 609566 | 3% | 59% | 52 | Search PERIFOSINE | Search PERIFOSINE |
6 | ALKYLPHOSPHOLIPIDS | 533341 | 2% | 79% | 34 | Search ALKYLPHOSPHOLIPIDS | Search ALKYLPHOSPHOLIPIDS |
7 | ET 18 OCH3 | 463458 | 2% | 81% | 29 | Search ET+18+OCH3 | Search ET+18+OCH3 |
8 | ERUFOSINE | 301763 | 1% | 89% | 17 | Search ERUFOSINE | Search ERUFOSINE |
9 | ERUCYLPHOSPHOCHOLINE | 243028 | 1% | 88% | 14 | Search ERUCYLPHOSPHOCHOLINE | Search ERUCYLPHOSPHOCHOLINE |
10 | ETHER LIPIDS | 230591 | 3% | 25% | 46 | Search ETHER+LIPIDS | Search ETHER+LIPIDS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BRACHWITZ, H , VOLLGRAF, C , (1995) ANALOGS OF ALKYLLYSOPHOSPHOLIPIDS - CHEMISTRY, EFFECTS ON THE MOLECULAR-LEVEL AND THEIR CONSEQUENCES FOR NORMAL AND MALIGNANT-CELLS.PHARMACOLOGY & THERAPEUTICS. VOL. 66. ISSUE 1. P. 39-82 | 227 | 87% | 85 |
2 | HOULIHAN, WJ , LOHMEYER, M , WORKMAN, P , CHEON, SH , (1995) PHOSPHOLIPID ANTITUMOR AGENTS.MEDICINAL RESEARCH REVIEWS. VOL. 15. ISSUE 3. P. 157-223 | 202 | 79% | 108 |
3 | VAN BLITTERSWIJK, WJ , VERHEIJ, M , (2013) ANTICANCER MECHANISMS AND CLINICAL APPLICATION OF ALKYLPHOSPHOLIPIDS.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS. VOL. 1831. ISSUE 3. P. 663-674 | 118 | 65% | 52 |
4 | JAFFRES, PA , GAJATE, C , BOUCHET, AM , COUTHON-GOURVES, H , CHANTOME, A , POTIER-CARTEREAU, M , BESSON, P , BOUGNOUX, P , MOLLINEDO, F , VANDIER, C , (2016) ALKYL ETHER LIPIDS, ION CHANNELS AND LIPID RAFT REORGANIZATION IN CANCER THERAPY.PHARMACOLOGY & THERAPEUTICS. VOL. 165. ISSUE . P. 114 -131 | 123 | 67% | 1 |
5 | KOSTADINOVA, A , TOPOUZOVA-HRISTOVA, T , MOMCHILOVA, A , TZONEVA, R , BERGER, MR , (2015) ANTITUMOR LIPIDS-STRUCTURE, FUNCTIONS, AND MEDICAL APPLICATIONS.ADVANCES IN PROTEIN CHEMISTRY AND STRUCTURAL BIOLOGY, VOL 101. VOL. 101. ISSUE . P. 27 -66 | 113 | 75% | 0 |
6 | GAJATE, C , MOLLINEDO, F , (2002) BIOLOGICAL ACTIVITIES, MECHANISMS OF ACTION AND BIOMEDICAL PROSPECT OF THE ANTITUMOR ETHER PHOSPHOLIPID ET-18-OCH3 (EDELFOSINE), A PROAPOPTOTIC AGENT IN TUMOR CELLS.CURRENT DRUG METABOLISM. VOL. 3. ISSUE 5. P. 491-525 | 188 | 53% | 112 |
7 | VERHEIJ, M , MOOLENAAR, WH , VAN BLITTERSWIJK, WJ , (2014) COMBINING ANTI-TUMOR ALKYL-PHOSPHOLIPID ANALOGS AND RADIOTHERAPY: RATIONALE AND CLINICAL OUTLOOK.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 14. ISSUE 4. P. 618 -628 | 81 | 77% | 3 |
8 | MOLLINEDO, F , (2007) ANTITUMOUR ETHER LIQUIDS: PROAPOPTOTIC AGENTS WITH MULTIPLE THERAPEUTIC INDICATIONS.EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 17. ISSUE 4. P. 385-405 | 101 | 72% | 21 |
9 | PRINCIPE, P , BRAQUET, P , (1995) ADVANCES IN ETHER PHOSPHOLIPIDS TREATMENT OF CANCER.CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY. VOL. 18. ISSUE 3. P. 155-178 | 112 | 89% | 24 |
10 | VAN BLITTERSWIJK, WJ , VERHEIJ, M , (2008) ANTICANCER ALKYLPHOSPHOLIPIDS: MECHANISMS OF ACTION, CELLULAR SENSITIVITY AND RESISTANCE, AND CLINICAL PROSPECTS.CURRENT PHARMACEUTICAL DESIGN. VOL. 14. ISSUE 21. P. 2061-2074 | 94 | 57% | 92 |
Classes with closest relation at Level 1 |